GHP Investment Advisors Inc. cut its position in shares of DaVita Inc. (NYSE:DVA – Free Report) by 3.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 44,083 shares of the company’s stock after selling 1,642 shares during the period. GHP Investment Advisors Inc.’s holdings in DaVita were worth $6,593,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Franklin Resources Inc. grew its position in shares of DaVita by 134.6% during the 3rd quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock valued at $8,885,000 after acquiring an additional 31,502 shares during the period. FMR LLC grew its holdings in DaVita by 659.9% in the third quarter. FMR LLC now owns 177,406 shares of the company’s stock valued at $29,082,000 after purchasing an additional 154,061 shares during the period. Atom Investors LP purchased a new stake in shares of DaVita in the third quarter valued at approximately $4,094,000. Assenagon Asset Management S.A. raised its stake in shares of DaVita by 201.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company’s stock worth $11,159,000 after buying an additional 49,885 shares during the period. Finally, Neo Ivy Capital Management acquired a new stake in DaVita in the 3rd quarter valued at $726,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.
Analyst Upgrades and Downgrades
Separately, Barclays upped their price objective on shares of DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $161.80.
DaVita Stock Down 2.8 %
Shares of DVA opened at $171.96 on Friday. The stock has a 50 day moving average price of $160.45 and a 200 day moving average price of $156.11. DaVita Inc. has a one year low of $108.76 and a one year high of $179.60. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37. The stock has a market capitalization of $14.10 billion, a price-to-earnings ratio of 18.55, a PEG ratio of 0.86 and a beta of 0.93.
DaVita Company Profile
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Further Reading
- Five stocks we like better than DaVita
- How to Plot Fibonacci Price Inflection Levels
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- Golden Cross Stocks: Pattern, Examples and Charts
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- Insider Trades May Not Tell You What You Think
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA – Free Report).
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.